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Myocardial SERCA2 activities are driven by ATP, and, as the majority of cytosolic Ca 2ϩ is pumped back into the SR by SERCA2, this mechanism is the major energy consumer in Ca . Metabolic and energetic studies have reported altered myocardial substrate utilization (7) and an improved postischemic energetic state (phosphocreatine-to-ATP ratio) (31) after SERCA overexpression. Examination of left ventricular (LV) mechanoenergetics has revealed that increased SERCA2 expression reduced the O 2 cost of LV contractility, whereas it did not alter work-dependent and -independent O 2 consumption (34 (3, 14, 25, 38) , there is a reason to believe that decreased SERCA2 activity/levels will affect the mechanoenergetic features of the heart. In cardiomyocytes from mice with inducible cardiomyocyte-specific excision of the Atp2a2 (Serca2) gene, the amplitude of Ca 2ϩ transients are reduced and the decay rates are prolonged (3, 5) . Using mathematical modeling to calculate ATP used for ion transport based on the recorded changes in intracellular ion concentrations (Ca 2ϩ , Na ϩ , and H ϩ ) and Ca 2ϩ -handling protein levels/activity from these cardiomyocytes, Li et al. (23) suggested that the ATP cost for ion transport was initially decreased followed by an increase at a later stage when the hearts present signs of heart failure (3, 5) . It should also be noted, however, that the stoichiometry of SERCA2 has been suggested to be reduced when SR Ca 2ϩ is elevated (43) , and as the mathematical model by Li et al. (23) did not include work-dependent ATP utilization (contractile efficiency), the aim of the present study was to examine the relationship between cardiac work and O 2 consumption in hearts from SERCA2 knockout (KO) mice. This allows for a direct assessment of the influence of SERCA2 elimination on mechanical efficiency, the energy cost for ECC and basal metabolism, as well as the efficiency of chemomechanical energy transduction (i.e., contractile efficiency).
METHODS

Animals. Serca2
flox/flox (SERCA2 FF) and Serca2 flox/flox Tg (␣MHC-MerCreMer) (SERCA2 KO) mice, backcrossed onto the B6/J background, have been previously described (3, 5) . The resulting adult SERCA2 KO mice do not present any abnormalities until rapid disruption of the Atp2a2 (Serca2) gene is induced by tamoxifen, whereas control SERCA2 FF mice remain unaffected (3, 5, 6) . Mice aged 8 -10 wk were injected once intraperitoneally with tamoxifen (40 mg/kg, dissolved in peanut oil) for the induction of myocardial Serca2 excision, a dose that has also been shown to prevent the transient tamoxifen-induced cardiomyopathy previously observed in transgenic ␣MHC-MerCreMer mice (17) .
All mice were housed in a room maintained at 21°C and 55% humidity with a 12:12-h light-dark cycle and were given ad libitum access to food and water. Mice were treated in accordance with guidelines on the accommodation and care of animals formulated by the European Convention for the Protection of Vertebrate Animals for Experimental and Other Scientific Purposes. Experiments were approved by the Animal Welfare Committee of the University of Tromsø.
Isolated heart perfusions. Mice were euthanized, and hearts excised for experiments at 4 or 7 wk after tamoxifen injection. After anesthesia (10 mg ip injection of pentobarbital sodium), hearts were excised, and the aorta was cannulated with an 18-gauge cannula. Hearts were perfused in the working or retrograde mode as previously described (9) . Modified Krebs-Henseleit bicarbonate buffer containing 2.5 mM Ca 2ϩ was supplemented with glucose (5 mM) and palmitate (0.7 mM, bound to 3% BSA) (1, 9) LV mechanical function was assessed using a 1.4-Fr conductance catheter (Millar Instruments, Houston, TX) inserted in the LV through the apex in electrically paced hearts (7 Hz). Hearts were exposed to different work loads by changing the preload (from 4 to 10 mmHg) and afterload (from 40 to 50 mmHg), and steady-state functional and contractile parameters were analyzed at various work loads (18) .
Energy expenditure of the heart was determined as myocardial O 2 consumption (MV O2) and was calculated based on measurements using the difference in O2 content in the buffer entering and leaving the heart and the coronary flow (2, 9, 15) . MV O2, stroke work [the area within the pressure-volume (P-V) loop], and P-V area (PVA; representing the total cardiac work) (18) was calculated at each work load. Mechanical efficiency, which connotes the efficiency by which the heart performs external work, was calculated as the ratio between stroke work and MV O2 (8) . Regression analysis of the relationship between PVA and MV O2 allowed for the determination of contractile efficiency (the inverse slope of this relationship) (40) . Work-independent MV O2 was measured in the retrograde perfused unloaded heart (MV O2 unloaded). By electrically arresting these hearts (elevation of extracellular K ϩ concentration), we could also measure the O2 cost of basal metabolism (MV O2 BM), and the difference between MV O2 unloaded and MV O2 BM was used to obtain the O2 cost of ECC (MV O2 ECC) (2, 9, 10, 15) .
Fluorodeoxyglucose uptake with a small animal positron emission tomography scanner. A small animal positron emission tomography (PET) scanner (microPET Focus 120, Concorde-CTI/Siemens, Knoxville, TN) was used to measure fluorodeoxyglucose ( 18 FDG; SteriPET, GE Healthcare, Oslo, Norway) uptake in cardiac tissue in mice 5 wk after tamoxifen injection. Food was removed 2 h before the experiment. Anesthesia was induced and maintained with 2% isoflurane and reduced to 1.5% isoflurane during the PET scanning.
18 FDG (8ϳ10 MBq, 0.1 ml) was injected intraperitonally 30 min before scanning in resting mice. Scanning time was 20 min with a 10-min transmission scan afterward for attenuation correction. Computed tomography (CT) scans were performed using microCAT (Micro CAT II, Imtek/Siemens), and a three-dimensional static image was reconstructed using the OSEM3D/MAP algorithm (2 OSEM3D iterations, 18 MAP iterations, ␤-value of 0.15). The matrix size was 128 ϫ 128 ϫ 95, and the image voxel size was 0.87 ϫ 0.87 ϫ 0.87 mm 3 . All data analysis was done using the PMOD software package (PMOD Technologies, Zurich, Switzerland). PET images were coregistered with the corresponding CT images. The apical half of the heart as the volume of interest was manually delineated from the CT images. The standard uptake value in the volume of interest was then obtained from the coregistered PET images and interpreted as ventricular 18 FDG uptake. mRNA expression/real-time quantitative RT-PCR. LV samples were immersed in RNAlater (Qiagen, Hilden, Germany), and total RNA was extracted according to the recommendations in the RNeasy Fibrous Tissue protocol (Qiagen). The RNA concentration was measured spectrophotometrically (NanoDrop, Witec, Switzerland) and stored at Ϫ80°C before use. cDNA was obtained from 1 g total RNA, and quantitative PCR was performed in an ABI PRISM 7900 HT Fast real-time thermal cycler using a 1:4 dilution of the cDNA and TaqMan Fast Universal PCR master mix (Applied Biosystems, Foster City, CA). Hypoxanthine phosphoribosyltransferase 1 (Hbrt1) was used as a housekeeping gene. Primer/probe sequences for Serca2, brain natriuretic peptide (Bnp), and myosin heavy chain-␣ and -␤ (Mhc-␣ and Mhc-␤, respectively) have been previously described (16) .
Statistical analysis. All data are expressed as means Ϯ SE. Differences between SERCA2 FF and SERCA2 KO mice were analyzed using an unpaired t-test. P values of Ͻ0.05 were considered significant.
RESULTS
Animals.
In agreement with previous studies (3, 25), we found that 4 wk after the injection of tamoxifen, myocardial mRNA expression of the Atp2a2 (Serca2) gene was reduced by 95% and remained the same at 7 wk (Table 1 ). There were no differences in total body weight between SERCA2 FF and KO mice at 4 or 7 wk after the injection of tamoxifen. Despite a previously reported progressive left atrial dilatation and cardiac enlargement (3, 25) , the LV-to-body weight ratio was reduced. At both 4 and 7 wk, SERCA2 KO hearts demonstrated a small but significant increase in the lung-to-body weight ratio (Table  1) . Myocardial mRNA expression of Bnp was unchanged, whereas expression of Mhc-␤ (but not Mhc-␣) was increased (Table 1) . This may suggest a reexpression of fetal genes that are a hallmark for the development of heart failure (33) .
LV mechanical function. Of the 19 SERCA2 KO hearts perfused 4 wk after Serca2 excision, 10 hearts showed marked signs of myocardial dysfunction during the initial phase of the perfusion (up to 15 min) and 4 hearts could not maintain sufficient external work (i.e., perfusion pressure equal to an afterload high of 50 mmHg in the aortic output line). These four hearts were therefore not included in the evaluation of heart function and mechanoenergetics in the SERCA2 KO group. In the control group, stable heart function was demonstrated almost immediately (within 2 min) in all hearts. Steadystate LV P-V loops were obtained using a conductance catheter in the LV, and a leftward shift of the LV P-V loop was observed in SERCA2 KO hearts ( Fig. 1 and Table 2 ). SERCA2 KO hearts demonstrated decreased cardiac output and stroke work as well as reduced LV systolic pressure and dP/dt max ( Table 2) . SERCA2 KO hearts also demonstrated impaired LV relaxation, as indicated by an elevated relaxation factor and decreased dP/dt min ( Table 2 ). These parameters of diastolic dysfunction were, however, not associated with increased LV end-diastolic pressure. Finally, coronary flow was found to be reduced in SERCA2 KO hearts at the 4-wk time point.
Hearts from SERCA2 KO mice at 7 wk after the excision of Serca2 showed very low ex vivo functional capacity, i.e., three of six SERCA2 KO hearts were not able to maintain a perfusion pressure equal to an afterload high of 50 mmHg in the aortic output line (data not shown). In another group of hearts, we increased the perfusate Ca 2ϩ concentration to 5 mM and found that, again, three of six SERCA2 KO hearts maintained afterload pressure (data not shown). Hearts from age-matched control mice showed normal function under both conditions. LV energetic function. Total energy expenditure (assessed by measuring MV O 2 ), stroke work (area of the P-V loop), and total mechanical energy (PVA) were measured under different loading conditions. These measurements were used to evaluate mechanical efficiency and the efficiency of the chemomechanical energy transduction (contractile efficiency). Figure 2A shows the relationship between MV O 2 and stroke work at three different workloads at the 4-wk time point. We found SERCA2 KO hearts to have a relatively higher MV O 2 at all workloads, demonstrating a marked decrease in mechanical efficiency (stroke work/MV O 2 ) in SERCA2 KO hearts compared with SERCA2 FF hearts (Fig. 2B) . We also examined the efficiency of the chemomechanical energy transduction through analysis of the relationship between total mechanical energy (PVA) and O 2 consumption (Fig. 3A) . The slope of this relationship was found to be 1.5-fold higher in SERCA2 KO hearts compared with SERCA2 FF hearts (Fig. 3A, inset) , which demonstrates that SERCA2 KO hearts show decreased contractile efficiency (1/slope) (40) . MV O 2 was also measured in mechanically unloaded retrogradely perfused hearts (MV O 2 unloaded ) to determine work-independent MV O 2 (i.e., the O 2 consumption required for nonmechanical processes). At 4 wk, SERCA2 KO hearts showed reduced MV O 2 unloaded (Fig. 3B ). This reduction in MV O 2 unloaded was not found to be due to a decreased cost of basal metabolism (MV O 2 BM ) but rather to a 30% reduction in MV O 2 ECC in SERCA2 KO hearts.
Taken together, we found that at 4 wk, despite the reduced O 2 cost for work-independent processes, SERCA2 KO hearts use more O 2 at any given increase in cardiac work (elevated work-dependent O 2 consumption), which leads to mechanical inefficiency at high work loads. Values are means Ϯ SE. Cardiac function was measured in isolated perfused hearts paced at 7 Hz, and steady-state parameters were obtained at preand and afterload values of 10 and 50 mmHg, respectively. LV pressures and volumes at end diastole and end systole as well as maximum positive and negative first derivatives of LV pressure (dP/dtmax and dP/dtmin) and LV relaxation time constants were obtained using a pressure-volume catheter. *P Ͻ 0.05 vs. SERCA2 FF mice. Due to the limited working capacity in hearts from SERCA2 KO mice at the 7-wk time point, we were not able to assess PVA or stroke work in these hearts. However, we did observe reduced MV O 2 unloaded (4.2 Ϯ 0.5 vs. 3.1 Ϯ 0.3, P ϭ 0.056) and MV O 2 ECC (3.3 Ϯ 0.4 vs. 2.3 Ϯ 0.2, P ϭ 0.033) at the 7-wk time point. It should be noted, however, that the power of this analysis was low, due to the limited number of hearts available.
Myocardial substrate uptake and oxidation. Measurements of myocardial glucose and fatty acid oxidation in isolated perfused working hearts revealed that the decreased cardiac work performed by SERCA2 KO hearts at 4 wk was accompanied by reduced fatty acid and glucose oxidation rates compared with hearts from SERCA2 FF mice (Fig. 4A) . When substrate utilization was adjusted for differences in cardiac output, the metabolic rates were similar in the two groups of hearts (Fig. 4B) . Substrate utilization at the 7-wk time point was not possible due to the lack of functional capacity of these hearts.
Finally, in vivo myocardial glucose uptake was assessed in a group of SERCA2 KO and SERCA2 FF mice at 5 wk after tamoxifen injection using microPET and 18 FDG. To verify similar 18 FDG injection within the two groups, brain FDG uptake was determined, and no differences were detected (188 Ϯ 14 vs. 207 Ϯ 12, P Ͼ 0.05; Fig. 5 ). Cardiac FDG uptake in SERCA2 KO mice was found to be markedly reduced compared with SERCA2 FF mice (78 Ϯ 9 vs. 141 Ϯ 23, P Ͻ 0.05), indicating that Serca2 excision also results in a reduced myocardial glucose uptake in vivo.
DISCUSSION
By analyzing LV function and the relationship between mechanical work and MV O 2 in hearts from conditional cardiacspecific SERCA2 KO mice, we directly measured how SERCA2 elimination influences mechanical function as well as energetic features of the heart. The present study shows that the reported decrease in the Ca 2ϩ transient amplitude in cardiomyocytes from SERCA2 KO mice (3) is accompanied by a decreased energy cost of ECC. As these hearts, however, show a marked decrease in the efficiency of the chemomechanical energy transduction (contractile efficiency), working hearts from cardiac-specific SERCA2 KO mice were found to be mechanically inefficient.
The effect of reduced activity and/or expression of SERCA2 in the cardiomyocyte will have major implications for ECC and thus contractile function of the heart. Accordingly, Ca 2ϩ transients measured in isolated cardiomyocytes from SERCA2 KO mice have decreased amplitude and longer decay rates as early as 6 days after gene excision (38) , changes that become more Fig. 3 . To elucidate underlying mechanisms contributing to decreased mechanical efficiency, we evaluated the mechanoenergetic properties of hearts from SERCA2 FF and SERCA2 KO mice 4 wk after Serca2 gene excision. The relationship between pressure-volume area (PVA) and MV O2 was measured at different workloads (A), and MV O2 was measured in retrogradely perfused unloaded and electrically paced hearts before and after electrical arrest (B). The bars in the inset in A are the group means (n ϭ 9 SERCA2 FF mice and 9 SERCA2 KO mice) of the slope of these relationships and represent workdependent O2 consumption. The r 2 values were 0.93 Ϯ 0.01 and 0.90 Ϯ 0.02 for SERCA2 FF and SERCA2 KO mice, respectively. B: MV O2 measured before (unloaded) and after [MV O2 for basal metabolism (BM)] electrical arrest in hearts from SERCA2 FF (n ϭ 11) and SERCA2 KO (n ϭ 10) mice. The O2 cost for excitation-contraction coupling (ECC) was calculated as the difference between unloaded MV O2 and the MV O2 for BM. Values are means Ϯ SE. *P Ͻ 0.05 vs. SERCA2 FF mice. pronounced when SERCA2 protein is reduced by 95% at 4 wk after gene excision (3) . Despite changes in the Ca 2ϩ transient measured in isolated cells, in vivo cardiac function in 4-wk-old KO mice has been reported to be relatively well preserved (3, 25) . At the 6-to 7-wk time point, however, KO mice demonstrate marked in vivo diastolic and systolic dysfunction (3, 14, 25) , and end-stage heart failure eventually develops, leading to death within a short time period (3, 25) . In the present study, isolated perfused hearts from SERCA2 KO mice at 4 wk after gene excision showed marked LV dysfunction, and, at the 7-wk time point, ex vivo SERCA2 KO hearts showed virtually no working capacity. The difference between in vivo and ex vivo cardiac function clearly points to the presence of compensatory systemic changes that support cardiac output in SERCA2 KO mice, such as increased circulating plasma norepinephrine (3). Our findings are further supported by a recent study from Land et al. (21) , where it was reported that the low amplitude of the Ca 2ϩ transients observed in KO cardiomyocytes were insufficient to trigger ventricular ejection when the recorded Ca 2ϩ transients from both 4-and 7-wk KO mice were used in a multiscale computational simulator of the whole heart response. Based on data obtained from ␤-adrenergic enhancement of Ca 2ϩ transients, and assuming increased venous return (as a consequence of elevated circulating catecholamine levels and the Frank-Starling effect), Land et al. (21) reported that the simulated P-V loops were comparable with those obtained from in situ experiments. This suggests that the increased ␤-adrenergic state contributes to maintain cardiac output in vivo in KO mice and may also explain why the ex vivo KO heart (in the absence of ␤-adrenergic stimuli and perfused under constant preload conditions) does not demonstrate elevated end-diastolic pressure, as demonstrated in vivo (3). This demonstrates the significance of an evaluation of ex vivo cardiac function to reveal the endogenous properties of the heart per se.
The majority (Ͼ90%) of ATP production in the heart is derived from mitochondrial oxidative phosphorylation, where fatty acids and glucose represent the main substrates. Although the development of heart failure in animal studies has often been associated with reactivation of the metabolic fetal gene program with decreased fatty acid oxidation and increased glucose utilization (primarily glycolysis), there is still a lack of consensus related to these changes (24) , and the causes and consequences of altered myocardial substrate metabolism in heart failure remain unclear. The discrepancy between investigations of substrate metabolism may be attributable to variation between species, the etiology of heart failure, and the progressive state of the disease (30, 37) . Heart failure in SERCA2 KO mice is associated with reduced glucose uptake in vivo, and ex vivo experiments have demonstrated decreases in both myocardial glucose and fatty acid oxidation. As KO hearts, however, also demonstrate decreased mechanical function, SERCA2 depletion did not seem to specifically influence the substrate preference for oxidative metabolism.
In the heart, ATP is used both for mechanical and nonmechanical purposes. While a range of studies (7, 32, 34) have examined the energetic effect of SERCA2 overexpression, the mechanoenergetic consequence of SERCA2 deletion has not previously been examined. Therefore, in the present study, we analyzed the relationship between cardiac work and energy expenditure after the elimination of SERCA2, using MV O 2 as a measure of energy expenditure. The O 2 cost related to nonmechanical processes include ECC, where the energy required for SERCA2 activity corresponds to ϳ70% (42) . Ca 2ϩ homeostasis in cardiomyocytes from SERCA2 KO mice is dependent on compensatory changes in Ca 2ϩ handling due to the marked reduction in SERCA2 abundance/activity and, consequently, SR Ca 2ϩ content. Accordingly, cardiomyocytes from SERCA2 KO mice show increased protein levels of the L-type Ca 2ϩ channel, sarcolemmal Ca 2ϩ -ATPase (PMCA), and NCX1 as well as increased L-type Ca 2ϩ current and NCX1 current density (3, 25, 38) . At the 4-wk time point, the NKA protein level is unaltered, whereas both the protein level and activity are decreased at 7 wk after gene deletion, changes that are also accompanied by intracellular Na ϩ accumulation (25) . A mathematical model, parameterized with the experimentally measured Ca 2ϩ dynamics from control and KO cardiomyocytes, suggests that the increased L-type Ca 2ϩ and NCX1 currents effectively maintain diastolic and systolic Ca 2ϩ levels after the loss of SERCA2 function (22) . Based on the stoichiometry of each Ca 2ϩ transporter, where SR Ca 2ϩ uptake by SERCA2 has been considered to be most energetically efficient (36) , the changes in myocardial Ca 2ϩ handling in SERCA2 KO mice is toward less energetically efficient Ca 2ϩ handling. As these changes are accompanied by a reduction in the amplitude of the Ca 2ϩ transient, however, it was not clear how this would influence the energy cost for ECC. In a recent study by Li et al. (23) , the ATP consumption for ion transport in SERCA2 KO cardiomyocytes was calculated, and, at the 4-wk time point, the reduced ATP requirement for SERCA2 was greater than the increased ATP consumed for NKA or PMCA, and thus the energy used for ion transport was decreased. In accordance with these predictions, we found, by direct measurements, reduced O 2 consumption in unloaded SERCA2 KO hearts (work-independent MV O 2 ), and this decrease in MV O 2 was indeed due to a decreased O 2 cost for ECC. The mathematical model further predicted that at the 7-wk time point, increased ATP consumption due to the combined rate of increased ATP consumption by NKA and PMCA would be greater than the decrease in ATP consumption by SERCA2. Due to the limited number of hearts in which O 2 consumption could be measured, we were not able to firmly determine the work-independent (unloaded) O 2 demand in these hearts.
The majority of energy expenditure in the heart is used for contractile activity. As this was not included in the mathematical models by Li et al. (22, 23) , we also evaluated the relationship between cardiac work and MV O 2 . Despite reduced work-independent O 2 consumption and reduced stroke work at a given work load, MV O 2 was not lower in SERCA2 KO hearts, and calculation of the ratio between LV stroke work and O 2 consumption showed that SERCA2 KO hearts clearly exhibited mechanical inefficiency. To elucidate the changes that may contribute to this inefficiency, we examined the efficiency of the chemomechanical energy transduction (i.e., contractile efficiency) by examining the relationship between total mechanical energy (assessed as PVA) and O 2 consumption (18, 40) . The slope of this relationship reflects the efficiency of the process of which O 2 consumption is converted to ATP synthesis (oxidative phosphorylation) and/or by which ATP hydrolysis is converted to cardiac mechanical work (cross-bridge cycling). In previous studies (7, 32, 34) , SERCA2 overexpression has been reported not to alter contractile efficiency, whereas the reduced contractile efficiency after heart failure has been found to be improved by increased SERCA2 expression (35) . In the present study, we demonstrated that SERCA2 KO hearts showed reduced contractile efficiency, as the increase in O 2 consumption for a given increase in cardiac work (PVA) was significantly higher compared with control hearts. Although the underlying mechanisms are not clear, one could speculate that the reduced SR Ca 2ϩ content and elevated intracellular Na ϩ concentration in cardiomyocytes from KO mice (3, 23, 25) can reduce mitochondrial Ca 2ϩ uptake as mitochondrial Ca 2ϩ uptake is most efficient when Ca 2ϩ is released from the SR compared with transsarcolemmal Ca 2ϩ influx (19, 20) . The reduced mitochondrial Ca 2ϩ uptake may not only hamper activation of the tricarboxylic acid cycle but also (as the redox state of NADH is closely linked to NADPH) reduce the mitochondrial antioxidant capacity and thus increase the emission of hydrogen superoxide (19) . As ROS have been shown to activate uncoupling proteins in the mitochondria (13) , this could contribute to the reduced efficiency observed in SERCA2 KO hearts. In addition, as the relaxation factor is elevated and thus relaxation is slowed, one may also speculate that the prolonged crossbridge cycling may consume ATP and O 2 without a gain in stroke volume (26) . Finally, it should also be noted that mechanical inefficiency would be further exacerbated in vivo due to the potential O 2 wasting effect after ␤-adrenergic stimulation (10, 29, 41) .
In conclusion, the ex vivo evaluation of the mechanical and energetic function of SERCA2 KO hearts in this study brings together experimental and mathematical modeling-based studies and has provided new knowledge on the mechanoenergetic changes after reduced SERCA2 activity. We have demonstrated by direct measurement that, although the decreased amplitude of Ca 2ϩ transients after Serca2 excision results in an overall decreased energy cost of the processes associated with ECC, contractile efficiency (the work-dependent O 2 cost) is markedly decreased in these hearts, resulting in mechanical inefficiency.
